78 results
Page 3 of 4
424B3
l1pm2pzs ffdkldcfy
2 Jun 21
Prospectus supplement
10:09am
424B3
m3xqn
2 Jun 21
Prospectus supplement
10:08am
6-K
EX-99.1
tn0xcpg cni516lai
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
6zadu40v18d
5 May 21
Amryt Reports Record Q1 2021 Financial and Operating Results
9:40am
20-F
EX-2.7
gwx huhy1l
30 Apr 21
Annual report (foreign)
12:53pm
20-F
ths4d7
30 Apr 21
Annual report (foreign)
12:53pm
424B3
fzfyr74f kde8jw
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
hwv6hpoc k1hbpx0
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
7slgeq
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
97rekpn9
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
l5utua 04iogc77hsm
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
w93o42tbfkjglz8
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.2
ex6uivqjvil13a
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-10.1
lisu0udmt66yw 8pst
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
37zg5 yef
5 Nov 20
Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
7:55am
6-K
EX-99.1
u6o6zq0k3re29akz0d
3 Nov 20
Current report (foreign)
8:45am
6-K
EX-99.1
e3nk386peo
29 Oct 20
Amryt Announces Positive Results from Phase 3 Trial of Filsuvez® In Epidermolysis Bullosa
8:00am
6-K
EX-99.1
oo4i38xo
6 Aug 20
Amryt Announces Q2 2020 Results and Issues Positive Revenue Guidance for Fy 2020
9:43am
424B4
965r5krbqjj8
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
3r9cddwgdyz86j
6 Jul 20
Registration statement (foreign) (amended)
5:28pm